课题基金 / 基金详情

A NOVEL MECHANISM OF ANDROGEN RECEPTOR ACTION

A NOVEL MECHANISM OF ANDROGEN RECEPTOR ACTION
雄激素受体作用的新机制
批准号:
7958495
负责人:
Charles T Roberts
金额:
$8.03万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-04 至 2010-04-30

项目摘要

项目成果

Charles T Roberts的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金, 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 该项目的目标是描述一种新的HER-2变异体(Herstatin)对前列腺癌中IGF-IR作用的影响。该项目的修订目标是: 1.研究Herstatin对前列腺癌细胞的作用。 2.检测前列腺癌细胞株和临床标本中Herstatin的表达。 3.研究Herstatin的表达调控。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The goal of this project is the characterization of the effects of a novel HER-2 variant (herstatin) on IGF-IR action in prostate cancer. The revised aims of this project are to: 1. Characterize the effects of herstatin in prostate cancer cells. 2. Evaluate expression of herstatin in prostate cancer cell lines and clinical samples. 3. Investigate regulation of herstatin expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
YR 50 PROJ- ROBERTS PRIMATE ISLET
MOLECULAR MECHANISMS OF HUMAN AND MURINE BETA CELL PROLIFERATION & REGENERATION
HERSTATIN: A NOVEL CANCER THERAPEUTIC
HERSTATIN: A NOVEL CANCER THERAPEUTIC
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data